Ingevity (NYSE:NGVT – Get Free Report) is one of 295 publicly-traded companies in the “Chemicals” industry, but how does it weigh in compared to its peers? We will compare Ingevity to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation.
Valuation & Earnings
This table compares Ingevity and its peers gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Ingevity | $1.17 billion | -$167.10 million | 36.98 |
| Ingevity Competitors | $8.01 billion | $230.87 million | 10.02 |
Ingevity’s peers have higher revenue and earnings than Ingevity. Ingevity is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Insider and Institutional Ownership
91.6% of Ingevity shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Ingevity shares are owned by company insiders. Comparatively, 13.9% of shares of all “Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Ingevity and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ingevity | 5.28% | 405.38% | 11.41% |
| Ingevity Competitors | -59.15% | -0.44% | -1.38% |
Volatility and Risk
Ingevity has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Ingevity’s peers have a beta of 0.93, indicating that their average share price is 7% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations for Ingevity and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ingevity | 0 | 3 | 2 | 0 | 2.40 |
| Ingevity Competitors | 3248 | 12218 | 14137 | 519 | 2.40 |
Ingevity presently has a consensus target price of $80.00, suggesting a potential upside of 27.25%. As a group, “Chemicals” companies have a potential upside of 8.10%. Given Ingevity’s stronger consensus rating and higher probable upside, equities analysts clearly believe Ingevity is more favorable than its peers.
Summary
Ingevity beats its peers on 8 of the 13 factors compared.
Ingevity Company Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
